CL2008000856A1 - Uso de una pasteurella multocida mutante acapsular y atenuada para inducir inmunidad protectora cruzada en un animal contra p. multocida virulenta que tiene un serotipo diferente al de p. multocida mutante. - Google Patents

Uso de una pasteurella multocida mutante acapsular y atenuada para inducir inmunidad protectora cruzada en un animal contra p. multocida virulenta que tiene un serotipo diferente al de p. multocida mutante.

Info

Publication number
CL2008000856A1
CL2008000856A1 CL200800856A CL2008000856A CL2008000856A1 CL 2008000856 A1 CL2008000856 A1 CL 2008000856A1 CL 200800856 A CL200800856 A CL 200800856A CL 2008000856 A CL2008000856 A CL 2008000856A CL 2008000856 A1 CL2008000856 A1 CL 2008000856A1
Authority
CL
Chile
Prior art keywords
multocide
multocid
acapsular
pasteurella
muting
Prior art date
Application number
CL200800856A
Other languages
English (en)
Inventor
Mahesh Anschutz Christin Kumar
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CL2008000856A1 publication Critical patent/CL2008000856A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CL200800856A 2007-03-26 2008-03-25 Uso de una pasteurella multocida mutante acapsular y atenuada para inducir inmunidad protectora cruzada en un animal contra p. multocida virulenta que tiene un serotipo diferente al de p. multocida mutante. CL2008000856A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91999707P 2007-03-26 2007-03-26

Publications (1)

Publication Number Publication Date
CL2008000856A1 true CL2008000856A1 (es) 2008-05-30

Family

ID=39616563

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800856A CL2008000856A1 (es) 2007-03-26 2008-03-25 Uso de una pasteurella multocida mutante acapsular y atenuada para inducir inmunidad protectora cruzada en un animal contra p. multocida virulenta que tiene un serotipo diferente al de p. multocida mutante.

Country Status (4)

Country Link
US (1) US20080241192A1 (es)
CL (1) CL2008000856A1 (es)
TW (1) TW200902056A (es)
WO (1) WO2008118902A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007109272A2 (en) * 2006-03-17 2007-09-27 The Board Of Trustees Of The Leland Stanford Junior University Energy generating systems for implanted medical devices
US20140147475A1 (en) * 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
WO2014147001A1 (en) 2013-03-18 2014-09-25 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
WO2015066292A1 (en) * 2013-11-01 2015-05-07 Merial Limited Attenuated pasteurella multocidavaccines & methods of making & use thereof
US10039818B2 (en) * 2016-05-05 2018-08-07 The United States Of America, As Represented By The Secretary Of Agriculture Attenuated pasteurella multocida strains
TW202219269A (zh) * 2020-09-30 2022-05-16 美國農業部 新型多殺性巴斯德氏菌株及具有ｈｙａＣ與ｎａｎＰ缺失之疫苗
CN114917331B (zh) * 2022-06-02 2025-03-28 金宇保灵生物药品有限公司 一种牛多杀性巴氏杆菌荚膜a型荚膜多糖疫苗及其制备方法
CN116790456B (zh) * 2022-09-27 2024-04-30 西南大学 一种牛源a型多杀性巴氏杆菌菌株、疫苗及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5780325A (en) * 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
WO1994011024A1 (en) * 1992-11-06 1994-05-26 Regents Of The University Of Minnesota Composition protective against p. multocida pasteurellosis infection
PT1350796E (pt) * 2002-04-05 2009-01-23 Merial Sas Bactérias gram-negativas atenuadas
NZ543771A (en) * 2003-07-02 2008-05-30 Biotechnology Res & Dev Acapsular Pasteurella multocida hyae deletion mutants
JP4981684B2 (ja) * 2004-12-22 2012-07-25 インターベツト・インターナシヨナル・ベー・ベー パストゥレラ・マルトシダワクチン

Also Published As

Publication number Publication date
WO2008118902A1 (en) 2008-10-02
TW200902056A (en) 2009-01-16
US20080241192A1 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
CL2008000856A1 (es) Uso de una pasteurella multocida mutante acapsular y atenuada para inducir inmunidad protectora cruzada en un animal contra p. multocida virulenta que tiene un serotipo diferente al de p. multocida mutante.
BRPI0814420A2 (pt) composição, e, uso de álcool alcoxilado.
BRPI0907663A8 (pt) composição que compreende hfo- 123 yf, composição que compreende hcfc-243db, composição que compreende hcfo- 1233xf, composição que comproeende hcfc- 244bb, uso das composições e método de uso das composições
BRPI0817811A2 (pt) Xilanases, ácidos nucleicos que codificam as mesmas e métodos para fabricação e uso das mesmas.
CO6382137A2 (es) Oligonucleótidos inmunoestimuladores
BR112012010676A2 (pt) partícula de alta eficiência que compreende um agente de benefício.
BRPI0920271A2 (pt) turbina de alta pressão de turbomáquina, e, turbomáquina
BRPI0812856A2 (pt) Composições de vacina de emulsão que compreendem antígeno e adjuvante na fase aquosa.
BRPI0815084A2 (pt) Tubo de perfuração, e, método.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
BRPI0815887A2 (pt) Uso de conduto metálico, processo e duto subterrâneo.
BRPI0815190A2 (pt) Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
EA201070219A1 (ru) Полимерные мультиэпитопные вакцины против гриппа
BRPI0820184A2 (pt) Agente de aperfeiçoamento do solo e uso do mesmo.
BRPI0807132A2 (pt) enzimas para o tratamento de lignocelulósicos, ácidos nucléicos que codificam as mesmas, e metodos e uso das mesmas
BRPI1008196A2 (pt) válvula tendo vedações de alta pressão e de baixa pressão.
TN2011000251A1 (en) Absorbent article with disposal wrapper
BRPI0717411A2 (pt) Uso de inibidores de iap
CL2008003712A1 (es) Compuestos derivados de tiadiazololoxifenilamidina o tiazoliloxifenilamidina; su procedimiento de preparacion; uso y procedimiento para combatir microorganismos no deseados; agente que comprende a dichos compuestos; compuestos intermediarios; y su procedimiento de preparacion.
BRPI0914069A2 (pt) composição de vacina para uso contra o influenza
BRPI1010617A2 (pt) uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição.
BRPI1006996A2 (pt) composição, método e uso
BRPI0912426A2 (pt) método executado por computador, computador, e sistema para uso com poço
BRPI0822472A2 (pt) Método, camundongo, e, composição